Scores on the PDSS were significantly improved for patients taking WAKIX compared with placebo
This means patients taking WAKIX reported falling asleep or getting drowsy less often during the day compared with patients who took placebo.
EDS Results
WAKIX was studied for the treatment of EDS in a clinical trial of 110 patients (aged 6-17 years) with narcolepsy.
WAKIX was compared with placebo (sugar pill) using the Pediatric Daytime Sleepiness Scale (PDSS) questionnaire.
This questionnaire uses an overall score to measure excessive daytime sleepiness by asking 8 questions about how often one falls asleep or gets drowsy during the day in situations such as:
This means patients taking WAKIX reported falling asleep or getting drowsy less often during the day compared with patients who took placebo.
Everyone responds to medication differently. Individual responses varied in the clinical trial.
Side Effects
In the 8-week clinical trial of 110 patients (aged 6-17 years) with narcolepsy, the most common side effects of WAKIX were headache and insomnia.
n indicates the number of patients who were treated with WAKIX.
Overall, the side effects seen in the clinical trial of patients aged 6-17 years with narcolepsy were similar to those seen in adult clinical trials.
In the clinical trials of adults with narcolepsy:
These are not all the possible side effects of WAKIX. Call your healthcare provider for medical advice about side effects.